- Home
- PHAR vs BHK Comparison
PHAR vs BHK Comparison
Compare PHAR & BHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- BHK
- Stock Information
- Founded
- PHAR 1988
- BHK 2001
- Country
- PHAR Netherlands
- BHK United States
- Employees
- PHAR N/A
- BHK N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- BHK Finance Companies
- Sector
- PHAR Health Care
- BHK Finance
- Exchange
- PHAR Nasdaq
- BHK Nasdaq
- Market Cap
- PHAR 618.3M
- BHK 609.2M
- IPO Year
- PHAR N/A
- BHK N/A
- Fundamental
- Price
- PHAR $8.20
- BHK $10.54
- Analyst Decision
- PHAR Strong Buy
- BHK
- Analyst Count
- PHAR 3
- BHK 0
- Target Price
- PHAR $27.00
- BHK N/A
- AVG Volume (30 Days)
- PHAR 5.6K
- BHK 188.3K
- Earning Date
- PHAR 03-13-2025
- BHK 01-01-0001
- Dividend Yield
- PHAR N/A
- BHK 8.34%
- EPS Growth
- PHAR N/A
- BHK N/A
- EPS
- PHAR N/A
- BHK 1.03
- Revenue
- PHAR $285,745,000.00
- BHK N/A
- Revenue This Year
- PHAR $20.08
- BHK N/A
- Revenue Next Year
- PHAR $9.22
- BHK N/A
- P/E Ratio
- PHAR N/A
- BHK $10.42
- Revenue Growth
- PHAR 30.64
- BHK N/A
- 52 Week Low
- PHAR $6.65
- BHK $9.02
- 52 Week High
- PHAR $13.20
- BHK $11.09
- Technical
- Relative Strength Index (RSI)
- PHAR 36.29
- BHK 51.09
- Support Level
- PHAR $8.49
- BHK $10.50
- Resistance Level
- PHAR $9.35
- BHK $10.64
- Average True Range (ATR)
- PHAR 0.55
- BHK 0.11
- MACD
- PHAR -0.17
- BHK 0.04
- Stochastic Oscillator
- PHAR 12.14
- BHK 75.61
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
About BHK Blackrock Core Bond Trust
Blackrock Core Bond Trust is a closed-ended management investment company. Its objective is to provide current income and capital appreciation. The trust seeks to achieve its investment objective by investing a majority of its managed assets in bonds that are investment-grade quality at the time of investment. The trust's investments will include a broad range of bonds, including corporate bonds, U.S. government and agency securities and mortgage-related securities.